Advertisement
Correspondence

Why Did the FDA Approve These Advertisements?

  • David Oaks mail

    To whom correspondence should be addressed. E-mail: oaks@mindfreedom.org

    Affiliation: MindFreedom International Eugene, Oregon, United States of America

    X
  • Published: February 28, 2006
  • DOI: 10.1371/journal.pmed.0030117

About the Author

David Oaks
MindFreedom International Eugene, Oregon, United States of America

Corresponding Author

Email: oaks@mindfreedom.org

Competing Interests

DO directs MindFreedom International, a nonprofit human rights organization. We are pro-choice on psychiatric drugs, and many of our members choose to take prescribed psychiatric drugs. However, we have engaged in protests of what we perceive as the psychiatric drug industry's unfair dominance of the mental health system.